US10085983, Compound AZD-9291 BDBM50029668 AZD-9291 Osimertinib WO2022090481, Example osimertinib US11111233, Example AZD9291 US9890168, Compound AZD-9291 US10227342, Example 24
- Gao, H; Yang, Z; Yang, X; Rao, Y Synthesis and evaluation of osimertinib derivatives as potent EGFR inhibitors. Bioorg Med Chem 25: 4553-4559 (2017)
- Zhou, P; Chen, G; Gao, M; Wu, J Design, synthesis and evaluation of the osimertinib analogue (C-005) as potent EGFR inhibitor against NSCLC. Bioorg Med Chem 26: 6135-6145 (2018)
- Liu, Q; Luo, Y; Li, Z; Chen, C; Fang, L Structural modifications on indole and pyrimidine rings of osimertinib lead to high selectivity towards L858R/T790M double mutant enzyme and potent antitumor activity. Bioorg Med Chem 36: (2021)